Drug comparisons
Insulin Degludec vs Insulin Glulisine Human
Insulin Degludec (Tresiba) vs Insulin Glulisine (Apidra): basal long-acting vs rapid-acting mealtime insulin. Complementary in diabetes treatment, not direct competitors.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when designing basal-bolus insulin regimens for type 1 or insulin-requiring type 2 diabetes.
Bottom line
Insulin degludec and insulin glulisine are complementary rather than alternatives, targeting basal versus prandial glucose control respectively.
All medication comparisons